Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study aims at investigating the therapeutic potential of recombinant human Nerve Growth Factor ( rhNGF ) eye drops treatment in patients with Retinitis Pigmentosa (RP) associated with cystoid macular edema (CME) in a phase II, randomized, double-masked, controlled clinical trial.
Epistemonikos ID: f55794e2a0ea08554dc44ba0cdf9ef8b012bd583
First added on: May 12, 2024